JGC
ASPN icon

J. Goldman & Co’s Aspen Aerogels ASPN Stock Holding History

J. Goldman & Co’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-534,665
Closed -$3.98M – 375
2023
Q1 		$3.98M Sell
534,665
-439,801
-45% -$4.37M 0.16% 162
2022
Q4 		$11.5M Buy
+974,466
New +$11.1M 0.56% 53

Other funds holding ASPN

KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

J. Goldman & Co's ASPN Position: Q2 2023 in Review

J. Goldman & Co sold out of Aspen Aerogels (ASPN) in Q2 2023, closing a stake of 534,665 shares — an estimated $3.98M sold.

J. Goldman & Co first reported a position in ASPN in Q4 2022 and held it in 2 quarters. The position peaked at $11.5M in Q4 2022. 159 funds tracked by Wall St. Rank hold ASPN as of Q2 2023.

  • J. Goldman & Co reported no remaining Aspen Aerogels position as of Q2 2023 after selling out during the quarter.
  • J. Goldman & Co sold 534,665 Aspen Aerogels shares in Q2 2023, an estimated $3.98M.
  • J. Goldman & Co first reported a position in Aspen Aerogels in Q4 2022 and held it in 2 quarters.
  • J. Goldman & Co's Aspen Aerogels position peaked at $11.5M in Q4 2022.
  • 159 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2023.

Based on J. Goldman & Co's 13F filing for Q2 2023, filed 14 Aug 2023.